Alzheimer's & Dementia

Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills. Alzheimer’s is the most common cause of dementia among older adults. Dementia is the loss of cognitive functioning—thinking, remembering, and reasoning—and behavioral abilities to such an extent that it interferes with a person’s daily life and activities.

Alzheimer’s Disease | Definition, Causes, Diagnosis & Treatment

Alzheimer’s Disease (AD) is the most common form of dementia worldwide (60-70% of all dementia cases) and is a progressive neurodegenerative disorder.

What is Dementia?

Differences Between Alzheimer's and Dementia

Alzheimer's Disease Causes

AAM - Genetics of Alzheimer's

Alzheimer's Disease Symptoms

Alzheimer's Disease Diagnosis

Alzheimer's Disease Treatments

AAM - The Search for a Cure to Alzheimer's

Alzheimer's Disease Questions

Alzheimer’s tangles and plaques: what’s the difference?

Alzheimer's Disease Epidemiology

See more featured articles »

Pollution and Alzheimer's

AAM - Air pollution and Alzheimer's

Is Alzheimer's Disease Transmissible?

Diet and Alzheimer's Disease

Types of Alzheimer's Disease

Stem Cell Therapy for Alzheimer's

Alzheimer's and Veganism

Biomarkers for Alzheimer's Disease

Alzheimer's Disease Prevention

Inflammation and Alzheimer's Disease

Integrated PET/MR for Alzheimer’s Disease

Gender and Alzheimer’s Risk

Alzheimer's Disease and Sleep Disruption

Does Herpesvirus Cause Alzheimer's?

Does Type 2 Diabetes Increase the Risk of Alzheimer’s Disease?

Can Statins Protect Against Alzheimer’s Disease?

Stress and Alzheimer's Disease

Alzheimer's Disease and the Microbiome

Amyloid Cascade Hypothesis

Omega-3 and Alzheimer’s Disease

Antibody Research and Alzheimer’s Disease

Alzheimer’s Disease and Calcium Supplements

Alzheimer’s Disease and Gingko Biloba

Do Antioxidants Benefit Patients with Alzheimer’s and Parkinson’s?

What Causes Dementia?

Dementia Diagnosis

Dementia Prevention

Dementia Symptoms

Dementia Treatment

Dementia with Lewy Bodies

Bright Light Therapy and Dementia

Aromatherapy for Dementia

Coconut Oil and Dementia

What is Mixed Dementia?

Transcutaneous Electrical Nerve Stimulation for Dementia

Childhood Dementia Causes

Mixed Dementia Prevention and Treatment

Mixed Dementia Symptoms and Diagnosis

Childhood Dementia Signs and Symptoms

Does Type 2 Diabetes Increase the Risk of Alzheimer’s Disease?

Parkinson's Compared to Dementia with Lewy Bodies (DLB)

Antidepressants and Dementia: Is There a Link?

Does Depression and Anxiety Increase the Risk of Dementia?

Migraines and Dementia

What are Amyloid Plaques?

Latest Alzheimer's & Dementia News and Research

Review: Diagnostic radiologists at higher risk of burnout

A review co-authored by Dr. Bradley Spieler, Vice-Chair of Scholarly Activity and Research in the Department of Radiology at LSU Health New Orleans School of Medicine, and Dr. Neil Baum, of Tulane's Department of Urology, reports that although burnout affects more than 50% of health care workers, diagnostic radiologists are at even higher risk.

4 Dec 2021

Elevated heart rate in old age may be an independent risk factor of dementia

Having an elevated resting heart rate in old age may be an independent risk factor of dementia, according to a study at Karolinska Institutet in Sweden published in the journal Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

3 Dec 2021

Cedars-Sinai researchers uncover the cause of UTI-induced delirium

Cedars-Sinai researchers have found that blocking the action of a protein called interleukin 6 (IL-6), part of the immune system, could resolve the delirium that often accompanies urinary tract infection (UTI) in elderly patients.

2 Dec 2021

Improving light availability can help normalize the altered sleep timing in people with schizophrenia

Disturbed sleep timing in people living with schizophrenia is more likely to be related to light exposure than to intrinsic biological factors.

2 Dec 2021

Trends and developments in current and future gut microbiome research

The gut microbiome is a complex system of trillions of bacteria, fungi and other organisms that perform a number of roles in the body.

From Atlantia Clinical Trials 2 Dec 2021

Noisy and quiet environments impact speech recognition in people with mild dementia

Listening to the spoken word in noisy environments is challenging for everyone. Acoustic studies show people with mild dementia struggle to understand speech in both noisy and quiet environments, highlighting the need for everyone to communicate clearly.

1 Dec 2021

Study could lead to new strategies to prevent or slow Alzheimer's disease

A gene mutation linked to Alzheimer's disease alters a signaling pathway in certain immune cells of individuals with the disease, according to a new study by scientists at Weill Cornell Medicine.

1 Dec 2021

Fast-tracked human stroke drug may also be a safe and powerful defense against dementia

A human stroke drug, fast-tracked by the Food and Drug Administration and soon entering Phase 3 clinical trials, shows intriguing signs that it might also be a safe and powerful defense against Alzheimer's and other forms of dementia.

1 Dec 2021

For older adults, smelling the roses may be more difficult

The reports from covid-19 patients are disconcerting. Only a few hours before, they were enjoying a cup of pungent coffee or the fragrance of flowers in a garden. Then, as if a switch had been flipped, those smells disappeared.

1 Dec 2021

Study sheds light on Aβ deposition patterns in the brain from external sources

Alzheimer's disease (AD) involves the deposition of a protein called amyloid β protein (Aβ) in the brain. This protein can build up in both the functional tissues, or "parenchyma", of the brain, and in the blood vessels.

30 Nov 2021

Potentially neurotoxic SARS-CoV-2 protein fragments

Researchers investigate potentially amyloidogenic peptide fragments that could be associated with the neurological symptoms of COVID-19 and long-COVID.

30 Nov 2021

Prevalence of type 2 diabetes is elevated in people with a psychiatric disorder

A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes (EASD)) finds that the prevalence of type 2 diabetes (T2D) is elevated in people with a psychiatric disorder compared with the general population.

30 Nov 2021

The mode of action of essential proteins involved in cancer and Alzheimer´s deciphered

The proteins that belong to the HAT family are essential for life as they transport amino acids across the cell membrane. Although the members of this family are practically identical, some transport certain amino acids and not others.

29 Nov 2021

Clinical drug research for the treatment of CNS and neurological disorders

Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders.

29 Nov 2021

People with dementia may not benefit from a clutter-free environment

A clutter-free environment may not help people with dementia carry out daily tasks - according to a new study from the University of East Anglia.

26 Nov 2021

Brain scans of athletes exposed to repetitive head impacts show white matter hyperintensities

Certain markers of injury to the brain's white matter, called white matter hyperintensities, can be seen on brain scans.

25 Nov 2021

Experts warn about increasing financial abuse of older people in the UK

Proposed changes to UK law risk substantially increasing financial abuse of older people, warn experts in The BMJ today.

25 Nov 2021

Retired elite rugby players who suffered repeated concussions have adverse mental health issues

Former professional rugby players are more likely to show signs of depression, anxiety and irritability compared to amateur rugby players and non-contact athletes, according to new research led by Durham University.

24 Nov 2021

Context-dependent, untangled persistency facilitates value signal coding across the brain

In 2019 University of California San Diego researchers discovered the area of the brain where "value decisions" are made.

24 Nov 2021

Integrated approach for optimization of treatment for multimorbid elderly patients with dementia

The CAREPATH project launched on 1st of July 2021, is a European Horizon 2020's project that proposes an ICT based solution for the optimization of clinical practice in the treatment and management of multimorbid patients with Mild Cognitive Impairment (MCI) or mild dementia (MD).

24 Nov 2021